바이러스 여과 시장 : 제품, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Virus Filtration Market was valued at USD 2.19 billion in 2023, expected to reach USD 2.49 billion in 2024, and is projected to grow at a CAGR of 14.35%, to USD 5.60 billion by 2030.

Virus filtration is a critical component of the broader bioprocessing and biotechnology landscape, particularly in the purification of biological products to ensure viral safety. This process encompasses the removal of viral contaminants from biological materials, which is crucial for the production of safe and effective biopharmaceuticals, including vaccines, monoclonal antibodies, and therapeutic proteins. The necessity of virus filtration stems from stringent regulatory standards ensuring that biological products are free of viruses that may pose infection risks. Applications extend across pharmaceutical manufacturing, biotechnology research, and food & beverage industries, with significant end-use in healthcare facilities and biopharmaceutical companies focused on vaccine production and gene therapies.

Market growth is primarily influenced by the increasing prevalence of chronic diseases and the rising demand for biologics, which fuel the need for rigorous viral clearance methods. Additionally, advancements in filter technologies, such as nanofiltration and improved membrane porosity, present lucrative opportunities for enhancing filtration efficiency and product yields. However, challenges such as high operational costs, regulatory hurdles, and the complexity of integrating filtration systems into existing processes can impede market expansion. The continuous emergence of new viral strains further complicates the landscape, necessitating ongoing research and development.

To capitalize on market opportunities, it is recommended to invest in innovative filtration solutions like single-use filtration and automation technologies, which can streamline operations and reduce contamination risks. Additionally, expanding research into the development of more robust filtration media that can efficiently capture a broader range of viruses holds promising potential. Companies should also collaborate with regulatory bodies to align product development with evolving standards, ensuring compliance and facilitating market entry. The virus filtration market remains dynamic, characterized by rapid technological advances and shifting demands, requiring stakeholders to maintain flexibility and adaptability. Emphasizing cost-effective, scalable solutions will be crucial for sustaining growth in this crucial sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Virus Filtration Market

The Virus Filtration Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rapid growth in pharmaceutical industry
  • Increasing prevalence of chronic diseases
  • Growth in R&D investment and efforts in the field
• Market Restraints
  • Certain limits in virus filtration capability
• Market Opportunities
  • Major scope in pharmaceutical outsourcing industry
  • Inclination towards the single-use product/technology
• Market Challenges
  • Validation of continuous virus filtration

Porter's Five Forces: A Strategic Tool for Navigating the Virus Filtration Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Virus Filtration Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Virus Filtration Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Virus Filtration Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Virus Filtration Market

A detailed market share analysis in the Virus Filtration Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Virus Filtration Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Virus Filtration Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Virus Filtration Market

A strategic analysis of the Virus Filtration Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Virus Filtration Market, highlighting leading vendors and their innovative profiles. These include Argonide Corporation, Asahi Kasei Medical Co., Ltd., Charles River Laboratories International, Inc., Clean Cells SAS, Danaher Corporation, Freudenberg Filtration Technologies SE & Co. KG, GE Healthcare, Lonza Group AG, MANN+HUMMEL International GmbH & Co. KG, Merck KGaA, Non-Change Enterprise Co., Ltd., Parker Hannifin Corporation, Sartorius AG, Synder Filtration, Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Virus Filtration Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Filtration Systems and Kits & Reagents.
• Based on Application, market is studied across Air Purification, Biologicals, Medical Devices, and Water Purification.
• Based on End User, market is studied across Biotechnology Companies, Contract Research Organizations, Medical Device Companies, and Pharmaceutical.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rapid growth in pharmaceutical industry
    • 5.1.1.2. Increasing prevalence of chronic diseases
    • 5.1.1.3. Growth in R&D investment and efforts in the field
  • 5.1.2. Restraints
    • 5.1.2.1. Certain limits in virus filtration capability
  • 5.1.3. Opportunities
    • 5.1.3.1. Major scope in pharmaceutical outsourcing industry
    • 5.1.3.2. Inclination towards the single-use product/technology
  • 5.1.4. Challenges
    • 5.1.4.1. Validation of continuous virus filtration
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Virus Filtration Market, by Product

• 6.1. Introduction
• 6.2. Filtration Systems
• 6.3. Kits & Reagents

7. Virus Filtration Market, by Application

• 7.1. Introduction
• 7.2. Air Purification
• 7.3. Biologicals
• 7.4. Medical Devices
• 7.5. Water Purification

8. Virus Filtration Market, by End User

• 8.1. Introduction
• 8.2. Biotechnology Companies
• 8.3. Contract Research Organizations
• 8.4. Medical Device Companies
• 8.5. Pharmaceutical

9. Americas Virus Filtration Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Virus Filtration Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Virus Filtration Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Argonide Corporation
• 2. Asahi Kasei Medical Co., Ltd.
• 3. Charles River Laboratories International, Inc.
• 4. Clean Cells SAS
• 5. Danaher Corporation
• 6. Freudenberg Filtration Technologies SE & Co. KG
• 7. GE Healthcare
• 8. Lonza Group AG
• 9. MANN+HUMMEL International GmbH & Co. KG
• 10. Merck KGaA
• 11. Non-Change Enterprise Co., Ltd.
• 12. Parker Hannifin Corporation
• 13. Sartorius AG
• 14. Synder Filtration, Inc.
• 15. Thermo Fisher Scientific, Inc.